T. Rowe Price Investment Management Inc. Sells 11,640 Shares of Bruker Corporation $BRKR

Key Points

• T. Rowe Price Investment Management Inc. reduced its stake in Bruker Corporation by 0.1%, selling 11,640 shares, bringing their total ownership to approximately 12.38 million shares worth $516.88 million.
• Bruker reported a missed earnings estimate of $0.32 per share compared to the expected $0.33, with quarterly revenue also falling short at $797.4 million.
• The company recently declared a quarterly dividend of $0.05 per share, giving an annual yield of 0.6%, with a dividend payout ratio of 38.46%.

T. Rowe Price Investment Management Inc. reduced its stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 0.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,383,350 shares of the medical research company's stock after selling 11,640 shares during the quarter. T. Rowe Price Investment Management Inc. owned about 8.17% of Bruker worth $516,882,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Teacher Retirement System of Texas grew its holdings in Bruker by 5.1% during the first quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock worth $1,212,000 after acquiring an additional 1,422 shares during the period. Fifth Third Bancorp increased its stake in Bruker by 54.2% in the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after buying an additional 390 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Bruker by 81.2% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company's stock worth $1,245,000 after acquiring an additional 13,367 shares in the last quarter. OneDigital Investment Advisors LLC raised its stake in shares of Bruker by 38.0% during the 1st quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock worth $230,000 after purchasing an additional 1,520 shares in the last quarter. Finally, UMB Bank n.a. lifted its stake in Bruker by 45.8% in the first quarter. UMB Bank n.a. now owns 1,325 shares of the medical research company's stock valued at $55,000 after acquiring an additional 416 shares during the last quarter. 79.52% of the stock is owned by institutional investors.

Insider Buying and Selling at Bruker

In related news, CEO Frank H. Laukien purchased 2,608 shares of the stock in a transaction on Friday, June 6th. The shares were purchased at an average price of $38.36 per share, with a total value of $100,042.88. Following the transaction, the chief executive officer directly owned 38,462,171 shares of the company's stock, valued at $1,475,408,879.56. This trade represents a 0.01% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 27.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently issued reports on BRKR shares. Stifel Nicolaus set a $40.00 price target on Bruker and gave the stock a "hold" rating in a research note on Tuesday, August 5th. Citigroup cut their price objective on shares of Bruker from $40.00 to $38.00 and set a "neutral" rating for the company in a research report on Monday, August 4th. Bank of America decreased their price target on shares of Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. UBS Group dropped their target price on Bruker from $57.00 to $45.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Finally, Wells Fargo & Company reduced their price target on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research report on Tuesday, August 5th. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Bruker currently has an average rating of "Hold" and an average target price of $51.30.

Bruker Stock Up 5.1%

Shares of BRKR stock traded up $1.74 during trading hours on Friday, hitting $35.54. 1,939,915 shares of the company were exchanged, compared to its average volume of 3,459,438. The company has a market capitalization of $5.39 billion, a PE ratio of 68.35, a PEG ratio of 2.79 and a beta of 1.16. The business has a 50 day moving average of $38.48 and a two-hundred day moving average of $41.05. Bruker Corporation has a 52 week low of $30.00 and a 52 week high of $72.94. The company has a current ratio of 1.61, a quick ratio of 0.70 and a debt-to-equity ratio of 1.31.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The firm had revenue of $797.40 million for the quarter, compared to analyst estimates of $811.17 million. During the same period in the prior year, the company earned $0.52 earnings per share. The firm's quarterly revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current fiscal year.

Bruker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be issued a $0.05 dividend. The ex-dividend date is Tuesday, September 23rd. This represents a $0.20 annualized dividend and a dividend yield of 0.6%. Bruker's dividend payout ratio (DPR) is presently 38.46%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.